Autres publications

20 novembre 2017

Depuis l'automne 2017, l'École d'éducation permanente de l'Université McGill, en partenariat avec le Montreal Medical Toxicology Initiative, offre aux professionnels de la santé un programme de formation en toxicologie clinique. Il est composé de trois modules (autonomes et interactifs avec quiz intégrés) couvrant les intoxications par salicylates, par acétaminophène et par alcools toxiques.

31 octobre 2017

Dans une enquête menée en même temps que le Washington Post, Bill Whitaker de 60 Minutes étudie les allégations selon lesquelles de puissants distributeurs pharmaceutiques ont contribué à faire progresser la crise des opioïdes en remplissant des commandes suspectes d'opioïdes. La pièce cite un exemple où une pharmacie située dans un village de Virginie-Occidentale, avec une population de quelques centaines de personnes, aurait commandé et reçu des millions de pilules d'opioïdes.

31 octobre 2017

Des chercheurs estiment que les services offerts par les centres antipoison du Royaume-Uni (téléphoniques et base de données accessible en ligne) empêchent environ 41 000 renvois par an de patients vers les services d'urgence en centre hospitalier.​

31 octobre 2017

Clinical pharmacists are integral to the care and safety of patients in the hospital, particularly in specialty and high-risk settings. Emergency departments (EDs) represent care environments that carry unique risks that may be addressed through the addition of clinical pharmacists specifically trained and/or experienced as an ED pharmacist. ED Pharmacists have demonstrated a positive impact on patient-specific outcome measures, timely medication administration, optimization of therapy, medication safety, and cost of care. ​We support 24-h staffing of emergency departments with dedicated ED pharmacists as part of the clinical care team. ACMT also supports studies to further define the impact and value of pharmacists in the ED and other areas of ED expansion such as urgent care and observation units.

29 août 2017

Fentanyl and its analogs are potent opioid receptor agonists, but the risk of clinically significant exposure to emergency responders is extremely low. To date, we have not seen reports of emergency responders developing signs or symptoms consistent with opioid toxicity from incidental contact with opioids. Incidental dermal absorption is unlikely to cause opioid toxicity. For routine handling of drug, nitrile gloves provide sufficient dermal protection. In exceptional circumstances where there are drug particles or droplets suspended in the air, an N95 respirator provides sufficient protection. Workers who may encounter fentanyl or fentanyl analogs should be trained to recognize the signs and symptoms of opioid intoxication, have naloxone readily available, and be trained to administer naloxone and provide active medical assistance. In the unlikely event of poisoning, naloxone should be administered to those with objective signs of hypoventilation or a depressed level of consciousness, and not for vague concerns such as dizziness or anxiety. In the absence of prolonged hypoxia, no persistent effects are expected following fentanyl or fentanyl analog exposures. Those with small subclinical exposures and those who awaken normally following naloxone administration will not experience long-term effects. While individual practitioners may differ, these are the positions of American College of Medical Toxicology and American Academy of Clinical Toxicology at the time written, after a review of the issue and scientific literature.

Pages

S'abonner à Autres publications